Reply to: Steroids in cystic fibrosis exacerbations: are we picking the right patients?
- PMID: 39362681
- DOI: 10.1183/13993003.01713-2024
Reply to: Steroids in cystic fibrosis exacerbations: are we picking the right patients?
Conflict of interest statement
Conflict of interest: V. Waters has nothing to disclose. B. Quon has nothing to disclose. F. Ratjen reports consultancy fees from Vertex Pharmaceuticals.
Comment on
-
A randomised trial of oral prednisone for cystic fibrosis pulmonary exacerbation treatment.Eur Respir J. 2024 Jun 6;63(6):2302278. doi: 10.1183/13993003.02278-2023. Print 2024 Jun. Eur Respir J. 2024. PMID: 38697648 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical